August 3, 2026
Tokyo, Japan — JEOL Ltd. (President & CEO: Izumi Oi) today announced the CRYO ARM™ 300S and CRYO ARM™ 200S, JEOL’s latest 300 kV and 200kV cold field-emission cryo-electron microscope that offers single-particle analysis (SPA), cryo-electron tomography (cryo-ET), 3DED/MicroED and beyond, all in one highly automated instrument. The CRYO ARM™ 300S and 200S are engineered to [...]
Launch of the New 300 kV Atomic Resolution Analytical Microscope “GRAND ARM™ 3”
August 3, 2026
JEOL Ltd. (President and CEO: Izumi Oi) has developed the new 300kV atomic resolution analytical microscope "GRAND ARM™ 3" and launched it on August 3, 2026. Development Background JEOL's flagship model, the 300kV atomic resolution electron microscope, has greatly enhanced its observation and analysis capabilities as the GRAND ARM™ 3. JEOL's joint development with CEOS [...]
August 3, 2026
New detectors enable multimodal SEM analysis with breakthrough performance MILWAUKEE, Wisconsin – Bruker today announced the launch of two groundbreaking detectors at Microscopy & Microanalysis (M&M) 2026: the eWARP™ TKD, a next-generation Transmission Kikuchi Diffraction (TKD) detector for nanoscale crystallographic characterization, and the XFlash® FlatQUAD™ 2L, the latest evolution of Bruker’s annular EDS detector, enabling simultaneous Energy Dispersive [...]
August 3, 2026
Collaboration, coordinated through NCSTAR at QIMR Berghofer, gives Queensland researchers a pathway to trial and validate MGI’s integrated DCSP framework — spanning DNA genomics, cell omics, spatial omics and proteomics — locally, fast-tracking their translation into real-world research and future clinical applications. Brisbane, Australia — MGI Australia, the local Australia and New Zealand team of MGI Tech Co., Ltd. (MGI), [...]
August 2, 2026
Tokyo, Japan — JEOL Ltd. (President & CEO: Izumi Oi) today announced the CRYO ARM™ 300S and CRYO ARM™ 200S, JEOL’s latest 300 kV and 200kV cold field-emission cryo-electron microscope that offers single-particle analysis (SPA), cryo-electron tomography (cryo-ET), 3DED/MicroED and beyond, all in one highly automated instrument. The CRYO ARM™ 300S and 200S are engineered to deliver high-resolution [...]
July 31, 2026
PROVIDENCE, R.I. – Nabsys 2.0, LLC ("Nabsys"), a pioneer in electronic genome mapping (EGM) technology, today announced a multi-year research collaboration with the Indiana University School of Medicine to develop and evaluate Electronic Genome Mapping applications for hematologic malignancies. As part of the collaboration, Kevin T.A. Booth, Ph.D., FACMG, Assistant Professor, Department of Medical and Molecular [...]
July 30, 2026
Combined sample-to-report solution pairs PacBio HiFi WGS with GenomOncology Pathology Workbench to support clinical labs in delivering configurable, reimbursement-aligned genomic reports across tumor types CLEVELAND -- GenomOncology (GO), a precision oncology software company specializing in genomic data interpretation and reporting, today announced an end-to-end workflow for somatic whole-genome sequencing (WGS) in oncology. The combined solution [...]
Phenomenex Appoints Dr. Lauryn Bailey as President
July 30, 2026
TORRANCE, CA, - Phenomenex Inc., a Danaher company and global leader in advanced technologies for the separation sciences, today announced the appointment of Dr. Lauryn Bailey as President of Phenomenex. Dr. Bailey joined Phenomenex in 2022 and has played an important role in advancing the company’s commercial and strategic priorities. “I’m honored to lead Phenomenex and [...]
Postnova Analyticsexpands its technologyportfoliothrough the acquisition of LS Instruments AG.
July 30, 2026
Effective 30 July 2026, LS Instruments AG has officially joined Postnova Analytics. The acquisition combines complementary technologies and expertise, creating a stronger platform for future innovation, product development and international growth. The addition of the LSI product range further strengthens the Postnova portfolio by significantly expanding its light scattering capabilities and creating complementary solutions for [...]
Xpress Genomics Joins Parse Biosciences’ Certified Service Provider Network
July 29, 2026
Stockholm-based service provider adds Evercode to its single cell sequencing offerings SEATTLE -- Parse Biosciences, the leading provider of scalable and accessible single cell sequencing, and a QIAGEN company, today announced that Xpress Genomics has joined its Certified Service Provider (CSP) program, becoming the first in the Nordic region. The Stockholm-based company will offer Parse's Evercode single cell [...]

